OncoCyte Ownership 2024 | Who Owns OncoCyte Now?
Institutional Ownership
13.94%
Insider Ownership
12.80%
Retail Ownership
73.26%
Institutional Holders
2.00
OncoCyte Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AWM INVESTMENT COMPANY, INC. | 13.28% | 0.44% | 1,097,175 | 342,889 | 45.46% | 3,236,666 | Jun 30, 2024 |
DEFENDER CAPITAL, LLC. | 0.67% | 0.06% | 55,220 | -665 | -1.19% | 162,899 | Jun 30, 2024 |
OncoCyte's largest institutional shareholder is AWM INVESTMENT COMPANY, INC., holding 13.28% of the company's total share outstanding, currently valued at $3.24M. The top 10 institutional shareholders own together 13.94% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AWM INVESTMENT COMPANY, INC. | 13.28% | 0.44% | 1,097,175 | 342,889 | 45.46% | 3,236,666 | Jun 30, 2024 |
DEFENDER CAPITAL, LLC. | 0.67% | 0.06% | 55,220 | -665 | -1.19% | 162,899 | Jun 30, 2024 |
The largest OncoCyte shareholder by % of total assets is AWM INVESTMENT COMPANY, INC.. The company owns 1.10M shares of OncoCyte (OCX), representing 0.44% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
AWM INVESTMENT COMPANY, INC. | 13.28% | 0.44% | 1,097,175 | 342,889 | 45.46% | 3,236,666 | Jun 30, 2024 |
DEFENDER CAPITAL, LLC. | 0.67% | 0.06% | 55,220 | -665 | -1.19% | 162,899 | Jun 30, 2024 |
As of Jun 30 2024, OncoCyte's largest institutional buyer is AWM INVESTMENT COMPANY, INC.. The company purchased 342.89K stocks of OCX, valued at $3.24M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
DEFENDER CAPITAL, LLC. | 0.67% | 0.06% | 55,220 | -665 | -1.19% | 162,899 | Jun 30, 2024 |
AWM INVESTMENT COMPANY, INC. | 13.28% | 0.44% | 1,097,175 | 342,889 | 45.46% | 3,236,666 | Jun 30, 2024 |
As of Jun 30 2024, OncoCyte's biggest institutional seller is DEFENDER CAPITAL, LLC.. The company sold -0.67K shares of OCX, valued at $162.90K.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
OncoCyte Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD VALLEY FORGE FUNDS | 0.12% | 63,657 | - | - | Mar 31, 2024 |
BRIDGEWAY FUNDS INC | 0.08% | 200,000 | - | - | Mar 28, 2024 |
FINANCIAL INVESTORS TRUST | 0.03% | 2,035,891 | - | - | Jan 31, 2024 |
ETF Managers Trust | 0.02% | 157,933 | - | - | Dec 31, 2023 |
QUANTITATIVE MASTER SERIES LLC | 0.02% | 110,088 | - | - | Mar 31, 2024 |
DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 10,247 | - | - | Mar 31, 2024 |
TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 2,507 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.01% | 4,181,409 | - | - | Mar 31, 2024 |
TIAA-CREF LIFE FUNDS | 0.01% | 17,581 | - | - | Mar 31, 2024 |
VANGUARD VALLEY FORGE FUNDS | 0.01% | 3,182 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 917,210 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 67,695 | - | - | Mar 31, 2024 |
Calvert Variable Products, Inc. | 0.00% | 5,296 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 62,284 | - | - | Feb 29, 2024 |
GPS Funds I | 0.00% | 7,151 | - | - | Mar 31, 2024 |
SunAmerica Specialty Series | 0.00% | 519 | - | - | Apr 30, 2021 |
PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 8,700 | - | - | Mar 28, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 27,904 | - | - | Mar 31, 2024 |
Global X Funds | 0.00% | 17,158 | - | - | Jan 31, 2024 |
STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 22,185 | - | - | Mar 31, 2024 |
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,668 | - | - | Mar 31, 2024 |
TIAA-CREF FUNDS | 0.00% | 780,812 | - | - | Mar 31, 2024 |
VANGUARD QUANTITATIVE FUNDS | 0.00% | 1,200 | - | - | Mar 31, 2024 |
FLEXSHARES TRUST | 0.00% | 17,756 | - | - | Jan 31, 2024 |
NORTHERN FUNDS | 0.00% | 32,058 | - | - | Mar 28, 2024 |
COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 226,593 | - | - | Mar 31, 2024 |
HC CAPITAL TRUST | 0.00% | 5,805 | - | - | Mar 31, 2024 |
RYDEX SERIES FUNDS | 0.00% | 574 | - | - | Dec 31, 2023 |
SEI INSTITUTIONAL INTERNATIONAL TRUST | 0.00% | 1,872,964 | - | - | Dec 31, 2023 |
FIDELITY SALEM STREET TRUST | 0.00% | 496,098 | - | - | Mar 31, 2024 |
SA FUNDS INVESTMENT TRUST | 0.00% | 1,900 | - | - | Mar 31, 2024 |
ProFunds | 0.00% | 1,286 | - | - | Mar 31, 2024 |
VANGUARD SCOTTSDALE FUNDS | 0.00% | 213,504 | - | - | Feb 29, 2024 |
T. Rowe Price Index Trust, Inc. | 0.00% | 2,321 | - | - | Feb 29, 2024 |
PGIM ETF TRUST | 0.00% | 5,470 | - | - | Feb 29, 2024 |
RYDEX DYNAMIC FUNDS | 0.00% | 317 | - | - | Dec 31, 2023 |
VALIC Co I | 0.00% | 22,303 | - | - | Feb 29, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 4,192 | - | - | Feb 29, 2024 |
PENN SERIES FUNDS INC | 0.00% | 1,800 | - | - | Mar 28, 2024 |
Guggenheim Active Allocation Fund | 0.00% | 358 | - | - | Feb 29, 2024 |
NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 7,856 | - | - | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 11,830 | - | - | Jan 31, 2024 |
RYDEX VARIABLE TRUST | 0.00% | 58 | - | - | Dec 31, 2023 |
VANGUARD WELLINGTON FUND | 0.00% | 19,280 | - | - | Feb 29, 2024 |
Dimensional ETF Trust | 0.00% | 20,766 | - | - | Jan 31, 2024 |
Meeder Funds | 0.00% | 195 | - | - | Mar 31, 2024 |
PROSHARES TRUST | 0.00% | 9,976 | - | - | Feb 29, 2024 |
NATIONWIDE MUTUAL FUNDS | 0.00% | 4,363 | - | - | Jan 31, 2024 |
Brighthouse Funds Trust II | 0.00% | 28,960 | - | - | Mar 31, 2024 |
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 57,637 | - | - | Mar 31, 2024 |
ADVANCED SERIES TRUST | 0.00% | 75,700 | - | - | Mar 28, 2024 |
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,223 | - | - | Dec 31, 2023 |
ETF Series Solutions | 0.00% | 384 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 6,635 | - | - | Mar 31, 2024 |
MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,653 | - | - | Feb 29, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 17,138 | - | - | Mar 31, 2024 |
PACIFIC SELECT FUND | 0.00% | 28,668 | - | - | Mar 31, 2024 |
Invesco Exchange-Traded Fund Trust II | 0.00% | 2,204 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 3,082 | - | - | Jan 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 4,457 | - | - | Dec 31, 2023 |
USAA MUTUAL FUNDS TRUST | 0.00% | 833 | - | - | Jan 31, 2024 |
Bridge Builder Trust | 0.00% | 12,751 | - | - | Mar 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 2,723 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 2,716 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 31,115 | - | - | Mar 31, 2024 |
Meeder Funds | 0.00% | 9 | - | - | Mar 31, 2024 |
BlackRock Variable Series Funds, Inc. | 0.00% | 8,559 | - | - | Mar 31, 2024 |
PRINCIPAL FUNDS, INC. | 0.00% | 9,751 | - | - | Feb 29, 2024 |
BLACKROCK FUNDS | 0.00% | 9,205 | - | - | Mar 28, 2024 |
Advisors' Inner Circle Fund III | 0.00% | 122 | - | - | Jan 31, 2024 |
SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 17,794 | - | - | Feb 29, 2024 |
WILSHIRE MUTUAL FUNDS INC | 0.00% | 210 | - | - | Dec 31, 2023 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 447 | 447 | - | Jan 31, 2024 |
John Hancock Funds II | 0.00% | 5,996 | - | - | Feb 29, 2024 |
VanEck ETF Trust | 0.00% | 17,571 | - | - | Jan 31, 2024 |
OncoCyte's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 63.66K shares, compromising 0.12% of its total assets.
OncoCyte Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 24 | 2 | - |
31 Mar, 24 | 2 | - |
31 Dec, 23 | 2 | - |
30 Sep, 23 | 2 | -95.74% |
30 Jun, 23 | 47 | -7.84% |
31 Mar, 23 | 51 | -10.53% |
31 Dec, 22 | 57 | -6.56% |
30 Sep, 22 | 61 | -12.86% |
30 Jun, 22 | 70 | -17.65% |
31 Mar, 22 | 85 | -5.56% |
31 Dec, 21 | 90 | -10.00% |
30 Sep, 21 | 100 | 5.26% |
30 Jun, 21 | 95 | 3.26% |
31 Mar, 21 | 92 | 43.75% |
31 Dec, 20 | 64 | 12.28% |
30 Sep, 20 | 57 | -9.52% |
30 Jun, 20 | 63 | 14.55% |
31 Mar, 20 | 55 | 3.77% |
31 Dec, 19 | 53 | - |
30 Sep, 19 | 53 | 10.42% |
30 Jun, 19 | 48 | 2.13% |
31 Mar, 19 | 47 | 235.71% |
31 Dec, 18 | 14 | -33.33% |
30 Sep, 18 | 21 | -19.23% |
30 Jun, 18 | 26 | -21.21% |
31 Mar, 18 | 33 | -8.33% |
31 Dec, 17 | 36 | 12.50% |
30 Sep, 17 | 32 | -5.88% |
30 Jun, 17 | 34 | 25.93% |
31 Mar, 17 | 27 | 3.85% |
31 Dec, 16 | 26 | 23.81% |
30 Sep, 16 | 21 | -25.00% |
30 Jun, 16 | 28 | -22.22% |
31 Mar, 16 | 36 | 800.00% |
31 Dec, 15 | 4 | - |
As of 30 Jun 24, 2 institutions are holding OncoCyte's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 24 | 1,152,395 | 42.24% |
31 Mar, 24 | 810,171 | -1.91% |
31 Dec, 23 | 825,936 | -0.94% |
30 Sep, 23 | 833,802 | -99.09% |
30 Jun, 23 | 91,824,895 | 64.98% |
31 Mar, 23 | 55,657,631 | -8.40% |
31 Dec, 22 | 60,759,707 | -8.16% |
30 Sep, 22 | 66,154,931 | -3.75% |
30 Jun, 22 | 68,729,099 | 26.45% |
31 Mar, 22 | 54,351,762 | -1.95% |
31 Dec, 21 | 55,431,734 | -1.99% |
30 Sep, 21 | 56,559,147 | 0.00% |
30 Jun, 21 | 56,557,421 | 3.69% |
31 Mar, 21 | 54,543,328 | 66.13% |
31 Dec, 20 | 32,831,885 | 4.93% |
30 Sep, 20 | 31,288,318 | -5.46% |
30 Jun, 20 | 33,095,782 | 19.62% |
31 Mar, 20 | 27,667,133 | 6.85% |
31 Dec, 19 | 25,893,584 | 36.65% |
30 Sep, 19 | 18,948,736 | 19.00% |
30 Jun, 19 | 15,923,897 | -1.08% |
31 Mar, 19 | 16,097,781 | 94.22% |
31 Dec, 18 | 8,288,262 | -4.80% |
30 Sep, 18 | 8,706,031 | -0.83% |
30 Jun, 18 | 8,779,294 | 1.65% |
31 Mar, 18 | 8,636,458 | 84.67% |
31 Dec, 17 | 4,676,817 | 6.02% |
30 Sep, 17 | 4,411,351 | 13.06% |
30 Jun, 17 | 3,901,931 | 3.34% |
31 Mar, 17 | 3,775,731 | 20.80% |
31 Dec, 16 | 3,125,497 | 1.55% |
30 Sep, 16 | 3,077,676 | 94.13% |
30 Jun, 16 | 1,585,335 | -5.11% |
31 Mar, 16 | 1,670,697 | 52.69% |
31 Dec, 15 | 1,094,163 | - |
OncoCyte (OCX) has 1.15M shares outstanding as of 30 Jun 24, up 42.24% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 24 | 13.94% | 12.44% |
31 Mar, 24 | 10.59% | 10.58% |
31 Dec, 23 | 10.00% | 9.42% |
30 Sep, 23 | 10.31% | 0.17% |
30 Jun, 23 | 77.07% | 3.53% |
31 Mar, 23 | 46.71% | 1.55% |
31 Dec, 22 | 54.84% | 1.76% |
30 Sep, 22 | 55.78% | 1.51% |
30 Jun, 22 | 60.80% | 1.75% |
31 Mar, 22 | 58.92% | 1.52% |
31 Dec, 21 | 62.34% | 1.63% |
30 Sep, 21 | 61.84% | 1.56% |
30 Jun, 21 | 63.01% | 1.43% |
31 Mar, 21 | 66.42% | 2.64% |
31 Dec, 20 | 50.14% | 2.32% |
30 Sep, 20 | 46.53% | 1.84% |
30 Jun, 20 | 50.27% | 2.48% |
31 Mar, 20 | 45.02% | 1.99% |
31 Dec, 19 | 47.51% | 3.57% |
30 Sep, 19 | 36.46% | 3.88% |
30 Jun, 19 | 30.64% | 2.57% |
31 Mar, 19 | 34.51% | 7.20% |
31 Dec, 18 | 21.90% | 4.68% |
30 Sep, 18 | 21.64% | 4.21% |
30 Jun, 18 | 22.68% | 3.05% |
31 Mar, 18 | 27.27% | 11.37% |
31 Dec, 17 | 15.49% | 7.62% |
30 Sep, 17 | 14.26% | 8.09% |
30 Jun, 17 | 13.27% | 7.81% |
31 Mar, 17 | 13.04% | 11.00% |
31 Dec, 16 | 10.89% | 8.11% |
30 Sep, 16 | 11.59% | 29.81% |
30 Jun, 16 | 6.23% | 14.44% |
31 Mar, 16 | 6.57% | 24.22% |
31 Dec, 15 | 5.21% | - |
As of 30 Jun 24, OncoCyte is held by 13.94% institutional shareholders, representing a 12.44% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | - |
31 Mar, 24 | - | -100.00% |
31 Dec, 23 | 1 | - |
30 Sep, 23 | - | -100.00% |
30 Jun, 23 | 19 | 216.67% |
31 Mar, 23 | 6 | -73.91% |
31 Dec, 22 | 23 | 53.33% |
30 Sep, 22 | 15 | -44.44% |
30 Jun, 22 | 27 | 3.85% |
31 Mar, 22 | 26 | -33.33% |
31 Dec, 21 | 39 | -27.78% |
30 Sep, 21 | 54 | 28.57% |
30 Jun, 21 | 42 | -38.24% |
31 Mar, 21 | 68 | 65.85% |
31 Dec, 20 | 41 | 20.59% |
30 Sep, 20 | 34 | -22.73% |
30 Jun, 20 | 44 | 46.67% |
31 Mar, 20 | 30 | 30.43% |
31 Dec, 19 | 23 | -23.33% |
30 Sep, 19 | 30 | - |
30 Jun, 19 | 30 | -26.83% |
31 Mar, 19 | 41 | 1266.67% |
31 Dec, 18 | 3 | -50.00% |
30 Sep, 18 | 6 | -40.00% |
30 Jun, 18 | 10 | -33.33% |
31 Mar, 18 | 15 | -28.57% |
31 Dec, 17 | 21 | 61.54% |
30 Sep, 17 | 13 | -40.91% |
30 Jun, 17 | 22 | 37.50% |
31 Mar, 17 | 16 | 45.45% |
31 Dec, 16 | 11 | 175.00% |
30 Sep, 16 | 4 | -63.64% |
30 Jun, 16 | 11 | -68.57% |
31 Mar, 16 | 35 | 775.00% |
31 Dec, 15 | 4 | - |
1 institutional shareholders have increased their position in OCX stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 24 | 1 | - |
31 Mar, 24 | 1 | - |
31 Dec, 23 | 1 | -50.00% |
30 Sep, 23 | 2 | -71.43% |
30 Jun, 23 | 7 | -61.11% |
31 Mar, 23 | 18 | -5.26% |
31 Dec, 22 | 19 | -13.64% |
30 Sep, 22 | 22 | -12.00% |
30 Jun, 22 | 25 | -24.24% |
31 Mar, 22 | 33 | 13.79% |
31 Dec, 21 | 29 | 3.57% |
30 Sep, 21 | 28 | -17.65% |
30 Jun, 21 | 34 | 183.33% |
31 Mar, 21 | 12 | 33.33% |
31 Dec, 20 | 9 | -25.00% |
30 Sep, 20 | 12 | 9.09% |
30 Jun, 20 | 11 | -21.43% |
31 Mar, 20 | 14 | -26.32% |
31 Dec, 19 | 19 | 18.75% |
30 Sep, 19 | 16 | 23.08% |
30 Jun, 19 | 13 | - |
31 Mar, 19 | - | -100.00% |
31 Dec, 18 | 3 | -25.00% |
30 Sep, 18 | 4 | -63.64% |
30 Jun, 18 | 11 | 37.50% |
31 Mar, 18 | 8 | 166.67% |
31 Dec, 17 | 3 | -57.14% |
30 Sep, 17 | 7 | 250.00% |
30 Jun, 17 | 2 | -33.33% |
31 Mar, 17 | 3 | 50.00% |
31 Dec, 16 | 2 | -66.67% |
30 Sep, 16 | 6 | -33.33% |
30 Jun, 16 | 9 | - |
31 Mar, 16 | - | - |
31 Dec, 15 | - | - |
1 institutional shareholders have reduced their position in OCX stock as of 30 Jun 24 compared to 1 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 24 | 2 | - | 1,152,395 | 42.24% | 13.94% | 12.44% | 1 | - | 1 | - |
31 Mar, 24 | 2 | - | 810,171 | -1.91% | 10.59% | 10.58% | - | -100.00% | 1 | - |
31 Dec, 23 | 2 | - | 825,936 | -0.94% | 10.00% | 9.42% | 1 | - | 1 | -50.00% |
30 Sep, 23 | 2 | -95.74% | 833,802 | -99.09% | 10.31% | 0.17% | - | -100.00% | 2 | -71.43% |
30 Jun, 23 | 47 | -7.84% | 91,824,895 | 64.98% | 77.07% | 3.53% | 19 | 216.67% | 7 | -61.11% |
31 Mar, 23 | 51 | -10.53% | 55,657,631 | -8.40% | 46.71% | 1.55% | 6 | -73.91% | 18 | -5.26% |
31 Dec, 22 | 57 | -6.56% | 60,759,707 | -8.16% | 54.84% | 1.76% | 23 | 53.33% | 19 | -13.64% |
30 Sep, 22 | 61 | -12.86% | 66,154,931 | -3.75% | 55.78% | 1.51% | 15 | -44.44% | 22 | -12.00% |
30 Jun, 22 | 70 | -17.65% | 68,729,099 | 26.45% | 60.80% | 1.75% | 27 | 3.85% | 25 | -24.24% |
31 Mar, 22 | 85 | -5.56% | 54,351,762 | -1.95% | 58.92% | 1.52% | 26 | -33.33% | 33 | 13.79% |
31 Dec, 21 | 90 | -10.00% | 55,431,734 | -1.99% | 62.34% | 1.63% | 39 | -27.78% | 29 | 3.57% |
30 Sep, 21 | 100 | 5.26% | 56,559,147 | 0.00% | 61.84% | 1.56% | 54 | 28.57% | 28 | -17.65% |
30 Jun, 21 | 95 | 3.26% | 56,557,421 | 3.69% | 63.01% | 1.43% | 42 | -38.24% | 34 | 183.33% |
31 Mar, 21 | 92 | 43.75% | 54,543,328 | 66.13% | 66.42% | 2.64% | 68 | 65.85% | 12 | 33.33% |
31 Dec, 20 | 64 | 12.28% | 32,831,885 | 4.93% | 50.14% | 2.32% | 41 | 20.59% | 9 | -25.00% |
30 Sep, 20 | 57 | -9.52% | 31,288,318 | -5.46% | 46.53% | 1.84% | 34 | -22.73% | 12 | 9.09% |
30 Jun, 20 | 63 | 14.55% | 33,095,782 | 19.62% | 50.27% | 2.48% | 44 | 46.67% | 11 | -21.43% |
31 Mar, 20 | 55 | 3.77% | 27,667,133 | 6.85% | 45.02% | 1.99% | 30 | 30.43% | 14 | -26.32% |
31 Dec, 19 | 53 | - | 25,893,584 | 36.65% | 47.51% | 3.57% | 23 | -23.33% | 19 | 18.75% |
30 Sep, 19 | 53 | 10.42% | 18,948,736 | 19.00% | 36.46% | 3.88% | 30 | - | 16 | 23.08% |
30 Jun, 19 | 48 | 2.13% | 15,923,897 | -1.08% | 30.64% | 2.57% | 30 | -26.83% | 13 | - |
31 Mar, 19 | 47 | 235.71% | 16,097,781 | 94.22% | 34.51% | 7.20% | 41 | 1266.67% | - | -100.00% |
31 Dec, 18 | 14 | -33.33% | 8,288,262 | -4.80% | 21.90% | 4.68% | 3 | -50.00% | 3 | -25.00% |
30 Sep, 18 | 21 | -19.23% | 8,706,031 | -0.83% | 21.64% | 4.21% | 6 | -40.00% | 4 | -63.64% |
30 Jun, 18 | 26 | -21.21% | 8,779,294 | 1.65% | 22.68% | 3.05% | 10 | -33.33% | 11 | 37.50% |
31 Mar, 18 | 33 | -8.33% | 8,636,458 | 84.67% | 27.27% | 11.37% | 15 | -28.57% | 8 | 166.67% |
31 Dec, 17 | 36 | 12.50% | 4,676,817 | 6.02% | 15.49% | 7.62% | 21 | 61.54% | 3 | -57.14% |
30 Sep, 17 | 32 | -5.88% | 4,411,351 | 13.06% | 14.26% | 8.09% | 13 | -40.91% | 7 | 250.00% |
30 Jun, 17 | 34 | 25.93% | 3,901,931 | 3.34% | 13.27% | 7.81% | 22 | 37.50% | 2 | -33.33% |
31 Mar, 17 | 27 | 3.85% | 3,775,731 | 20.80% | 13.04% | 11.00% | 16 | 45.45% | 3 | 50.00% |
31 Dec, 16 | 26 | 23.81% | 3,125,497 | 1.55% | 10.89% | 8.11% | 11 | 175.00% | 2 | -66.67% |
30 Sep, 16 | 21 | -25.00% | 3,077,676 | 94.13% | 11.59% | 29.81% | 4 | -63.64% | 6 | -33.33% |
30 Jun, 16 | 28 | -22.22% | 1,585,335 | -5.11% | 6.23% | 14.44% | 11 | -68.57% | 9 | - |
31 Mar, 16 | 36 | 800.00% | 1,670,697 | 52.69% | 6.57% | 24.22% | 35 | 775.00% | - | - |
31 Dec, 15 | 4 | - | 1,094,163 | - | 5.21% | - | 4 | - | - | - |
OncoCyte Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of OncoCyte's stock was made by BROADWOOD PARTNERS, L.P. on Apr 15 2024, selling - shares at $30.60 per share (valued at -). The last insider buy of OCX was made by BROADWOOD PARTNERS, L.P. on Apr 15 2024, buying 2,420,000 shares at $2.92 per share (worth $7.06M).
OncoCyte Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | 3 | - | - |
Q2 2024 | 9 | 1 | 900.00% |
Q4 2023 | 1 | 2 | 50.00% |
Q3 2023 | 1 | - | - |
Q2 2023 | 18 | 3 | 600.00% |
Q1 2023 | 5 | 3 | 166.67% |
Q4 2022 | 6 | 14 | 42.86% |
Q3 2022 | 21 | 1 | 2100.00% |
Q2 2022 | 38 | 11 | 345.45% |
Q1 2022 | 18 | - | - |
Q4 2021 | - | 1 | - |
Q3 2021 | 4 | 5 | 80.00% |
Q2 2021 | 17 | 5 | 340.00% |
Q1 2021 | 9 | - | - |
Q4 2020 | 17 | 4 | 425.00% |
Q3 2020 | 6 | - | - |
Q2 2020 | 10 | 1 | 1000.00% |
Q1 2020 | 14 | 4 | 350.00% |
Q4 2019 | 2 | - | - |
Q3 2019 | 14 | 4 | 350.00% |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by OncoCyte's insiders, as of Q3 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q3 2024 | - | - | - |
Q2 2024 | 4 | - | - |
Q4 2023 | - | - | - |
Q3 2023 | - | - | - |
Q2 2023 | 4 | - | - |
Q1 2023 | - | - | - |
Q4 2022 | 3 | - | - |
Q3 2022 | 9 | - | - |
Q2 2022 | 28 | 6 | 466.67% |
Q1 2022 | 6 | - | - |
Q4 2021 | - | - | - |
Q3 2021 | - | - | - |
Q2 2021 | - | - | - |
Q1 2021 | 5 | - | - |
Q4 2020 | - | 4 | - |
Q3 2020 | 6 | - | - |
Q2 2020 | 2 | - | - |
Q1 2020 | 9 | 1 | 900.00% |
Q4 2019 | 2 | - | - |
Q3 2019 | 8 | 2 | 400.00% |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of OncoCyte's stocks.
OncoCyte Peer Ownership
Ticker | Company |
---|---|
GTH | Genetron Holdings Limited |
PSNL | Personalis, Inc. |
PRPH | ProPhase Labs, Inc. |
XGN | Exagen Inc. |
SERA | Sera Prognostics, Inc. |
BNR | Burning Rock Biotech Limited |
ISPC | iSpecimen Inc. |
CSTL | Castle Biosciences, Inc. |
DRIO | DarioHealth Corp. |
OLK | Olink Holding AB (publ) |
BDSX | Biodesix, Inc. |
FONR | FONAR Corporation |
INBS | Intelligent Bio Solutions Inc. |
PRPO | Precipio, Inc. |
TRIB | Trinity Biotech plc |
STIM | Neuronetics, Inc. |
SHC | Sotera Health Company |
OCX Ownership FAQ
Who Owns OncoCyte?
OncoCyte is owned by institutional shareholders (13.94%), insiders (12.80%), and public (73.26%). The largest institutional shareholder of OncoCyte is AWM INVESTMENT COMPANY, INC. (13.28% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.12% of total shares).
Who are the major institutional shareholders of OncoCyte?
OncoCyte's major institutional shareholders are AWM INVESTMENT COMPANY, INC., and DEFENDER CAPITAL, LLC.. The top five shareholders own together 13.94% of the company's share outstanding.
How many OncoCyte shareholders are there?
As of Jun 2024, there are 2 institutional shareholders of OncoCyte.
What percentage of OncoCyte is owned by AWM INVESTMENT COMPANY, INC?
AWM INVESTMENT COMPANY, INC owns 1.1M shares of OncoCyte, representing 13.28% of the company's total shares outstanding, valued at $3.24M (as of Jun 2024).
What percentage of OncoCyte is owned by DEFENDER CAPITAL, LLC?
As of Jun 2024, DEFENDER CAPITAL, LLC holds 55.22K shares of OncoCyte (OCX), compromising 0.67% of the company, valued at $162.9K.